Emerging roles for cholesterol in Huntington's disease

Related Experiment Video

Updated: May 30, 2026

Enrichment of Mammalian Tissues and Xenopus Oocytes with Cholesterol
10:12

Enrichment of Mammalian Tissues and Xenopus Oocytes with Cholesterol

Published on: March 25, 2020

Marta Valenza1, Elena Cattaneo

  • 1Department of Pharmacological Sciences and Centre for Stem Cell Research, Università degli Studi di Milano, Milan, Italy.

Trends in Neurosciences
|July 22, 2011
PubMed

Insights

Alterations in cholesterol homeostasis are linked to Huntington's disease (HD). The huntingtin protein may regulate cholesterol biosynthesis, offering potential therapeutic targets for HD treatment.

Area of Science:

  • Neurodegenerative diseases
  • Cholesterol metabolism
  • Huntington's disease pathogenesis

Background:

  • Emerging evidence links cholesterol homeostasis disruptions to Huntington's disease (HD).
  • Cholesterol alterations are observed in HD cell and animal models, but underlying mechanisms remain unclear.
  • It is undetermined if cholesterol changes are a cause or consequence of HD pathogenesis.

Purpose of the Study:

  • To review current research on cholesterol perturbations in Huntington's disease.
  • To discuss potential mechanisms linking cholesterol homeostasis to HD.
  • To explore the role of huntingtin protein in cholesterol biosynthesis.

Main Methods:

  • Literature review of studies investigating cholesterol in HD models.
  • Analysis of findings on cholesterol content and metabolism in HD.
  • Discussion of the potential role of huntingtin protein in cholesterol regulation.

Main Results:

  • Huntingtin protein may play a role in regulating cholesterol biosynthesis.
  • Observed cholesterol alterations in HD models require further mechanistic investigation.
  • The precise involvement of cholesterol homeostasis in HD pathogenesis is still under investigation.

Conclusions:

  • Understanding cholesterol's role in HD pathophysiology is crucial.
  • Investigating huntingtin protein's function in cholesterol metabolism may reveal therapeutic strategies.
  • Targeting cholesterol pathways could offer new treatment avenues for Huntington's disease.

More Related Videos

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species07:08

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species

Published on: February 27, 2018

Cholesterol Efflux Assay07:54

Cholesterol Efflux Assay

Published on: March 6, 2012

Related Concept Videos

Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Cholinesterases: Distribution and Function01:22

Cholinesterases: Distribution and Function

Cholinesterases are a group of serine hydrolase enzymes that play a crucial role in the breakdown of choline esters. The two primary types of cholinesterases are acetylcholinesterases (AChEs) and butyrylcholinesterase (BuChEs), which differ in their distribution, function, and substrate specificity. AChEs, also known as true cholinesterases, specifically hydrolyze acetylcholine, while BuChEs, often referred to as pseudocholinesterases, can hydrolyze various choline esters, including...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...